Xiangyu Medical Co. Ltd. A (688626) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.009x

Based on the latest financial reports, Xiangyu Medical Co. Ltd. A (688626) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥18.05 Million ≈ $2.64 Million USD) by net assets (CN¥2.04 Billion ≈ $298.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 688626 equity financing ratio to measure how much of total assets are equity-financed.

Xiangyu Medical Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Xiangyu Medical Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Xiangyu Medical Co. Ltd. A earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Xiangyu Medical Co. Ltd. A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Xiangyu Medical Co. Ltd. A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Black Peony Group Co Ltd SHG:600510	0.000x
Prospect Capital Corporation NASDAQ:PSEC	0.022x
Dynamic Holding Co. Ltd. TW:3715	-0.034x
Hengkang Medical Group Co Ltd SHE:002219	0.005x
Altareit PA:AREIT	0.051x
Kunshan Guoli Electronic Technology Co Ltd SHG:688103	0.012x
Helix Energy Solutions Group Inc NYSE:HLX	0.015x
Zhongnanhong Culture Group Co Ltd SHE:002445	0.032x

Annual Cash Flow Conversion Efficiency for Xiangyu Medical Co. Ltd. A (2017–2024)

The table below shows the annual cash flow conversion efficiency of Xiangyu Medical Co. Ltd. A from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see Xiangyu Medical Co. Ltd. A (688626) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.05 Billion ≈ $300.68 Million	CN¥178.59 Million ≈ $26.13 Million	0.087x	-19.63%
2023-12-31	CN¥2.11 Billion ≈ $308.38 Million	CN¥227.91 Million ≈ $33.35 Million	0.108x	+12.36%
2022-12-31	CN¥1.94 Billion ≈ $283.86 Million	CN¥186.70 Million ≈ $27.32 Million	0.096x	+12.88%
2021-12-31	CN¥1.95 Billion ≈ $284.70 Million	CN¥165.88 Million ≈ $24.27 Million	0.085x	-70.72%
2020-12-31	CN¥743.29 Million ≈ $108.77 Million	CN¥216.40 Million ≈ $31.67 Million	0.291x	+2.18%
2019-12-31	CN¥547.28 Million ≈ $80.08 Million	CN¥155.94 Million ≈ $22.82 Million	0.285x	+59.30%
2018-12-31	CN¥414.81 Million ≈ $60.70 Million	CN¥74.20 Million ≈ $10.86 Million	0.179x	-70.12%
2017-12-31	CN¥99.09 Million ≈ $14.50 Million	CN¥59.31 Million ≈ $8.68 Million	0.599x	--

About Xiangyu Medical Co. Ltd. A

SHG:688626 China Medical Devices

Market Cap

$1.04 Billion

CN¥7.11 Billion CNY

Market Cap Rank

#8725 Global

#2099 in China

Share Price

CN¥44.44

Change (1 day)

-0.54%

52-Week Range

CN¥39.61 - CN¥87.12

All Time High

CN¥116.87